Study of the Activity of the Ventral Intermediate Nucleus of the Thalamus Under Ecological Conditions in Essential Tremor.

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Essential tremor (ET) is a neurological disorder that affects nearly 0.9% of the world's population. High-frequency Deep Brain Stimulation (DBS) of the ventral-intermediate nuclei of the thalamus (VIM) has been proven as an effective second-line treatment for severe forms of ET. The arrival on the market of the PERCEPT™ (new stimulator/recorder, Medtronic, Minneapolis, USA) now allows, in addition to the stimulation delivery, the recording of intracerebral activity at a distance from surgery, in a non-invasive way and in ecological condition at home. Investigators aim at recording the variations of thalamic Local Field Potentials (LFP) oscillations, in ecological condition, during rest and movement, with and without deep brain stimulation, once a week, between M3 and M6 post surgery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Advanced disabling and drug-resistant tremor

• Receiving deep brain stimulation treatment with implantation of the PERCEPT™ device according to standard care

• Chronic progressive cardiac, renal, hematological or pulmonary diseases under treatment.

• Patient aged between 18 to 75 years

• Normal brain MRI

• MATTIS score ≥ 130/144 or MOCA ≥ 24/30

• Subject affiliated with or benefiting from a social security plan

• Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research)

Locations
Other Locations
France
CHU de Bordeaux
RECRUITING
Bordeaux
Contact Information
Primary
Edouard COURTIN, Dr
edouard.courtin@chu-bordeaux.fr
05 57 82 12 42
Backup
Olivier Branchard
olivier.branchard@chu-bordeaux.fr
05 57 82 06 97
Time Frame
Start Date: 2023-05-03
Estimated Completion Date: 2026-05-03
Participants
Target number of participants: 10
Treatments
Experimental: experimental arm
Patient with ET and Receiving deep brain stimulation treatment with implantation of the PERCEPT™ device
Sponsors
Collaborators: MINDig
Leads: University Hospital, Bordeaux

This content was sourced from clinicaltrials.gov